High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
暂无分享,去创建一个
P. Hegde | T. Powles | Z. Modrušan | H. Koeppen | J. Rosenberg | M. S. van der Heijden | S. Mariathasan | K. Yuen | E. Kadel | R. Banchereau | Shravan Madireddi | Y. Chen | S. Keerthivasan | J. Grogan | D. McDermott | Ning Leng | Congfen Li | K. Hashimoto | Li-fen Liu | D. Tayama | P. Williams | Vinita Gupta | M. Huseni | D. Rishipathak | A. Thastrom | Xiadong Shen | Li-Fen Liu | N. Leng | Shilpa Keerthivasan | Kobe Yuen | Deepali Rishipathak | Z. Modrusan